Asia Pacific

Throughout Asia Pacific, The Union provides technical assistance, research and training programmes in tobacco control, tuberculosis (TB), non-communicable diseases, road safety, and health data.

You are here:

Asia Pacific

Published on

Updated:

Health Challenges in Asia Pacific

1,060,000

TB incidence in Indonesia in 2022

31,000

drug-resistant TB incidence in Philippines in 2022

13,600

deaths from TB in Vietnam in 2022

Members of The Union Asia Pacific Region

The Union is divided into seven regions to provide a platform for addressing lung health and related issues from a regional perspective. This structure offers members opportunities to network with colleagues who face the same regional challenges and contributes to The Union's deep understanding of local issues. 

The Union Asia Pacific Region is made up of close to 400 individuals and organisations.

Find out about our members

​​​​​​​Our work in Asia Pacific

Members in Action

United knowledge sharing for local impact

The 9th Asia Pacific Region Conference of the International Union Against Tuberculosis and Lung Disease (APRC 2024), will take place from 26 – 29 April 2024 at Taipei International Convention Centre in Taipei, Taiwan. With the theme of “Shaping a Safer World through high-quality holistic healthcare”, the program will include the fields of tuberculosis, emerging respiratory infectious disease, universal health coverage and environmental factors on communicable disease (especially tuberculosis) and non-communicable disease, including asthma, chronic obstructive pulmonary disease, lung cancer, and interstitial lung disease.

For more information, please visit the conference website www.aprc2024.org

Read more

UNION NEWS FROM THE Asia pacific REGION

PHILIPPINES RESTORES THE FDA AND DOH’S AUTHORITY TO REGULATE TOBACCO PRODUCTS

Published on 5 July 2022

After a 11-year battle, the Philippines’ Supreme Court ruled to uphold the authority of the Food and Drug Administration (FDA) and the Department of Health (DOH) to regulate all products affecting health, including tobacco products. This reverses a 2011 petition filed by the Philippine Tobacco Institute—its members include Philip Morris Philippines Manufacturing, Inc., Fortune Tobacco Corp., La Suerte Cigar, and Cigarette Factory—to prevent tobacco products regulation by the FDA and DOH.